NortonLifeLock (NLOK) Competitors

$19.70
-0.33 (-1.65%)
(As of 05/6/2024 ET)

NLOK vs. DT, ESTC, CDAY, GWRE, PCTY, APPN, PTC, API, CIDM, and BTX

Should you be buying NortonLifeLock stock or one of its competitors? The main competitors of NortonLifeLock include Dynatrace (DT), Elastic (ESTC), Ceridian HCM (CDAY), Guidewire Software (GWRE), Paylocity (PCTY), Appian (APPN), PTC (PTC), Agora (API), Cinedigm (CIDM), and Brooklyn ImmunoTherapeutics (BTX).

NortonLifeLock vs.

NortonLifeLock (NASDAQ:NLOK) and Dynatrace (NYSE:DT) are both large-cap information companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, community ranking, dividends, analyst recommendations, profitability, earnings, valuation and risk.

94.9% of NortonLifeLock shares are owned by institutional investors. Comparatively, 94.3% of Dynatrace shares are owned by institutional investors. 3.3% of NortonLifeLock shares are owned by company insiders. Comparatively, 0.5% of Dynatrace shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Dynatrace has a consensus price target of $61.08, indicating a potential upside of 30.60%. Given Dynatrace's higher possible upside, analysts plainly believe Dynatrace is more favorable than NortonLifeLock.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NortonLifeLock
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Dynatrace
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
2.81

In the previous week, Dynatrace had 7 more articles in the media than NortonLifeLock. MarketBeat recorded 8 mentions for Dynatrace and 1 mentions for NortonLifeLock. Dynatrace's average media sentiment score of 0.71 beat NortonLifeLock's score of 0.00 indicating that Dynatrace is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NortonLifeLock
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Dynatrace
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Dynatrace has a net margin of 14.44% compared to NortonLifeLock's net margin of 0.00%. Dynatrace's return on equity of 11.92% beat NortonLifeLock's return on equity.

Company Net Margins Return on Equity Return on Assets
NortonLifeLockN/A N/A N/A
Dynatrace 14.44%11.92%7.43%

NortonLifeLock has higher revenue and earnings than Dynatrace. NortonLifeLock is trading at a lower price-to-earnings ratio than Dynatrace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NortonLifeLock$2.82B4.00$817.05M$1.4313.78
Dynatrace$1.16B11.88$107.96M$0.6670.86

NortonLifeLock has a beta of 0.76, suggesting that its stock price is 24% less volatile than the S&P 500. Comparatively, Dynatrace has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500.

Dynatrace received 161 more outperform votes than NortonLifeLock when rated by MarketBeat users. However, 100.00% of users gave NortonLifeLock an outperform vote while only 67.51% of users gave Dynatrace an outperform vote.

CompanyUnderperformOutperform
NortonLifeLockOutperform Votes
53
100.00%
Underperform Votes
No Votes
DynatraceOutperform Votes
214
67.51%
Underperform Votes
103
32.49%

Summary

Dynatrace beats NortonLifeLock on 11 of the 17 factors compared between the two stocks.

Get NortonLifeLock News Delivered to You Automatically

Sign up to receive the latest news and ratings for NLOK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NLOK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NLOK vs. The Competition

MetricNortonLifeLockData Processing, Hosting, and Related Services IndustryInformation SectorNASDAQ Exchange
Market Cap$11.26B$11.26B$2.90B$7.80B
Dividend Yield2.31%2.31%3.69%3.96%
P/E Ratio13.786.896.8117.65
Price / Sales4.004.003.0780.46
Price / CashN/AN/AN/A28.60
Price / BookN/AN/AN/A4.42
Net Income$817.05MN/AN/A$217.17M
7 Day Performance-5.11%-2.55%1.45%2.77%
1 Month Performance-11.06%-5.53%-7.03%-1.99%
1 Year Performance14.87%7.43%-6.31%8.89%

NortonLifeLock Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DT
Dynatrace
4.933 of 5 stars
$45.31
-2.6%
$61.08
+34.8%
+7.4%$13.34B$1.16B68.654,180News Coverage
Gap Down
ESTC
Elastic
2.3701 of 5 stars
$102.24
-1.6%
$111.26
+8.8%
+89.4%$10.31B$1.07B222.262,886News Coverage
CDAY
Ceridian HCM
2.8401 of 5 stars
$61.37
-1.0%
$76.38
+24.5%
+2.6%$9.58B$1.45B2,046.358,526Positive News
High Trading Volume
GWRE
Guidewire Software
2.2481 of 5 stars
$110.40
-2.2%
$115.11
+4.3%
+51.8%$9.09B$905.34M-178.063,415
PCTY
Paylocity
4.7427 of 5 stars
$155.16
-1.6%
$205.13
+32.2%
-1.3%$8.74B$1.17B52.426,100Positive News
APPN
Appian
4.3091 of 5 stars
$37.44
-2.4%
$48.86
+30.5%
-2.9%$2.75B$545.36M-24.472,243Earnings Report
Analyst Revision
PTC
PTC
4.6682 of 5 stars
$177.44
-1.8%
$202.40
+14.1%
+38.1%$21.21B$2.10B90.077,231
API
Agora
0.8484 of 5 stars
$2.49
-2.0%
$3.20
+28.5%
-18.2%$267.65M$141.54M-2.861,001Gap Down
CIDM
Cinedigm
0 of 5 stars
$0.80
-2.4%
N/AN/A$55.05M$72.33M-16.00140
BTX
Brooklyn ImmunoTherapeutics
0 of 5 stars
$1.77
-3.3%
N/A+30.6%$12.06MN/A-0.78N/AAnalyst Forecast
News Coverage
Gap Up

Related Companies and Tools

This page (NASDAQ:NLOK) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners